Back to School: How biopharma can reboot drug development. Access exclusive analysis here

Alpharma, Idea deal

IDEA granted ALO exclusive rights to commercialize Diractin ketoprofen ( IDEA-033) in the U.S. to

Read the full 154 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE